Category: Other Policy Priorities (Page 4)

March 4, 2015

Medicare Part D Non-Interference Letter

The Alliance for Aging Research signed a letter expressing opposition to proposals that would allow the Secretary of Health and Human Services (HHS) to interfere in private prescription drug negotiations in the Medicare Part D program.
February 6, 2015

Con. Res. Supporting Quality of Life for Prostate Cancer Patients Support Letter

The Alliance for Aging Researched signed on to a Urology Policy Forum (UPF) letter expressing support for Con. Res., the Supporting Quality of Life for Prostate Cancer Patients. 
January 15, 2015

Alliance Takes Part in Hill Briefing on Medicare Advantage

Yesterday the Alliance had the privilege of participating in a Capitol Hill briefing hosted by the Coalition for Medicare Choices (CMC) on the value of Medicare Advantage.
January 14, 2015

The Medicare Advantage Experience: Perspectives from Providers and Beneficiaries

The Coalition for Medicare Choices (CMC) invites you to a briefing to hear from providers, health care stakeholders, and members of the coalition about why Medicare Advantage is such a critical choice for nearly 16 million Americans who rely on it.
September 17, 2013

One Year Later: FDASIA and its Impact for Diseases of Aging

Join us for One Year Later: FDASIA and its Impact for Diseases of Aging.
May 13, 2013

Tweets Do Tell: Alzhemier’s Not a High Priority for Research Funding

An article by Cynthia Bens, Alliance vice president of public policy
September 28, 2012

AHRQ Submitted Comments on Key Questions for Stroke Prevention in Atrial Fibrillation–2012

September 28, 2012 Agency for Health Research and Quality Effective Health Care Program Scientific Resource Center, Oregon EPC…
September 4, 2012

PQRS Submitted Comments on Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule

September 4, 2012 Marilyn Tavenner Acting Administrator  Centers for Medicare & Medicaid Services Department of Health and Human Services Attn: CMS-1590-P P.O. Box 8013 Baltimore, MD 21244-8013  RE: Comments on Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule Dear Administrator Tavenner: Because of the growing impact atrial fibrillation (AFib) is having on our aging population, the AFib Optimal Treatment Task Force, comprised of 12 leading organizations in the thrombosis space, formed in 2011 to raise awareness of the impact of the disease and to explore issues related to the process used by healthcare providers to assess both stroke and bleeding risk in making decisions about anticoagulation therapy for patients with AFib. We appreciate the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule. Our comments on the proposed rule will be limited to a new measure #1525, Chronic Anticoagulation Therapy, which is under consideration by CMS for inclusion in the Physician Quality Reporting System (PQRS) for CY2013. Recent expert consensus led by the AFib Optimal Treatment Task Force supports the use of this measure but with an additional recommendation to encourage routine and proper bleeding risk assessment. We urge you to include a modified version of measure #1525 in the final rule that encourages a bleeding risk assessment in addition to a stroke risk assessment to ensure that Medicare beneficiaries with AFib are presented with all treatment options that may be available for them.
March 5, 2012

PCORI Submitted Comments on National Priorities for Research and Research Agenda

March 15, 2012 Joe V. Selby, M.D., M.P.H. Executive Director Patient Centered Outcomes Research Institute 1701 Pennsylvania Ave, NW Suite 300 Washington, D.C. 20006 RE: Comments on PCORI National Priorities for Research and Research Agenda Dear Dr. Selby: The groups below comprise a task force of leading organizations in the thrombosis space that are exploring issues related to optimal stroke prevention in atrial fibrillation. Participants in this task force represent various audiences—from patients to health care providers—that are unified by the desire to improve the way in which stroke and bleeding risk are assessed in atrial fibrillation patients and ensure proper treatment of these patients. In our capacity as health care stakeholders, we support the Patient Centered Outcomes Research Institute’s (PCORI) mission to improve health care delivery and outcomes by producing and promoting high integrity, evidence-based information that comes from research guided by patients, caregivers and the health care community. As such we appreciate the opportunity to comment on PCORI’s national research priorities and research agenda.
October 4, 2011

AHRQ Submitted Comments on Key Questions for Stroke Prevention in Atrial Fibrillation

AHRQ Comments Home > Aging Topics > Atrial Fibrillation > AHRQ Comments October 14, 2011 Agency for Healthcare Research and Quality Effective Health Care Program Scientific Resource Center, Oregon EPC Mail Code: BICC 3181 S.W. Sam Jackson Park Road Portland, Oregon 97239-3098 RE: Comment on Key Questions for Stroke Prevention in Atrial Fibrillation Dear Sir or Madam: Thank you for the opportunity to comment on AHRQ’s key questions related to the Effective Health Care Program’s comparative effectiveness review of stroke prevention in atrial fibrillation. We believe this is an important time to review in light of the growing impact atrial fibrillation has on our aging population and the uncertainty that exists about the best way to treat older patients with the condition.